Efficacy and safety of thymosin combined with anticancer therapy for esophageal cancer: a systematic review and meta-analysis of randomized controlled trials.
Saved in:
| Title: | Efficacy and safety of thymosin combined with anticancer therapy for esophageal cancer: a systematic review and meta-analysis of randomized controlled trials. |
|---|---|
| Authors: | Sun T; Department of Oncology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.; Henan University of Chinese Medicine, Zhengzhou, China., Zhao R; Paediatric Hospital, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China., Zhang C; The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China., Shan X; Department of Oncology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.; Henan University of Chinese Medicine, Zhengzhou, China., Zhang Y; Department of Oncology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China., Zheng Y; Department of Oncology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.; Henan University of Chinese Medicine, Zhengzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 May 29; Vol. 17, pp. 1812375. Date of Electronic Publication: 2026 May 29 (Print Publication: 2026). |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1812375 |
